Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Primary Myelofibrosis × Thalidomide × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 6 Waldenstrom Macroglobulinemia 1 Recurrence 1 Precancerous Conditions 1 Neoplasms, Plasma Cell 1 Medulloblastoma 1 Mastocytosis, Systemic 1 Lymphoma, Mantle-Cell 1 Liver Neoplasms 1 Leukemia, Large Granular Lymphocytic 1 Ependymoma 1 Carcinoma, Hepatocellular 1

Interventions

ruxolitinib 23 Cyclophosphamide 12 Whole-Body Irradiation 10 Tacrolimus 9 fludarabine phosphate 8 fludarabine 8 Stem Cell Transplantation 8 Mycophenolic Acid 8 Specimen Handling 7 Peripheral Blood Stem Cell Transplantation 7 Azacitidine 6 Busulfan 5 navitoclax 4 Melphalan 4 Biopsy 4 fedratinib 3 Sirolimus 3 Methotrexate 3 Injections 3 venetoclax 2 selinexor 2 parsaclisib 2 luspatercept 2 letermovir 2 itacitinib 2 bomedemstat 2 INCB057643 2 INCB039110 2 Hematopoietic Stem Cell Transplantation 2 Granulocyte Colony-Stimulating Factor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡